Volume Spike Investor

Titanium Metals Corp. (NYSE: TIE) is seeing severe options trading.  The October $10 calls have traded more than 14,000 contracts with open interest of just 1,867 contracts as traders place large buy orders at the offer.  The action comes a day after I recommended buying TIE on valuation due to comments from Boeing on the [...]

General Electric Co. (NYSE:GE) is running up a second day on an analyst call as its price target was raised to $18 from $15 at Goldman Sachs.  Shares are up over 2% at $14.81 on about 1.5 million shares as of 9:15 AM EST.  This is a tiny fraction of the average volume for a [...]

Palm Inc. (NASDAQ: PALM) is getting slapped this morning.  Shares are down over 5% at $14.20 after a $14.98 close.  We have also seen some 250,000 shares trade hands as of 9:09 AM EST, although average volume is now over 12 million shares.  Credit Suisse cut the rating to Neutral based partly on performance and [...]

Two VIVUS (VVUS) competitors are running despite the notion that the great study results may actually increase the competitive threat against them.  It seems the thought is that this will make them hurry with more data now… This is running over into other diabetes and obesity emerging stocks as well. Orexigen Therapeutics Inc. (NASDAQ: OREX) [...]

VIVUS Inc. (NASDAQ: VVUS) is soaring on what is already exponential volume.  The company’s interim update showed that patients taking Qnexa reduced their weight by up to 14.7% on average in one trial, and the drug also showed improvement in blood pressure and diabetes symptoms and risk factors. Vivus’ second study showed an average weight [...]